WO2004086853A2 - Generation de plantes a resistance pathogene amelioree - Google Patents

Generation de plantes a resistance pathogene amelioree Download PDF

Info

Publication number
WO2004086853A2
WO2004086853A2 PCT/US2004/010174 US2004010174W WO2004086853A2 WO 2004086853 A2 WO2004086853 A2 WO 2004086853A2 US 2004010174 W US2004010174 W US 2004010174W WO 2004086853 A2 WO2004086853 A2 WO 2004086853A2
Authority
WO
WIPO (PCT)
Prior art keywords
plant
sequence
plants
polypeptide
pprll
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2004/010174
Other languages
English (en)
Other versions
WO2004086853A3 (fr
Inventor
Allan Lammers
Stanley R. Bates
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agrinomics LLC
Original Assignee
Agrinomics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agrinomics LLC filed Critical Agrinomics LLC
Publication of WO2004086853A2 publication Critical patent/WO2004086853A2/fr
Anticipated expiration legal-status Critical
Publication of WO2004086853A3 publication Critical patent/WO2004086853A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance

Definitions

  • Lsd6 and Lsd7 are dominant mutations that confer heightened disease and result in the development of spontaneous necrotic lesions and elevated levels of salicylic acid (Weymann et al 1995 Plant Cell 7:2013-2022).
  • a number of recessive mutations confer P. parasitica resistance, including ssi2, in the SSI2 gene encoding a stearoyl-ACP desaturase (Kachroo et al. 2001 Proc Natl Acad Sci U S A 98:9448-9453), mpk4, in a MAP kinase gene (Petersen et al.
  • Activation tagging in plants refers to a method of generating random mutations by insertion of a heterologous nucleic acid construct comprising regulatory sequences (e.g., an enhancer) into a plant genome.
  • the regulatory sequences can act to enhance transcription of one or more native plant genes; accordingly, activation tagging is a fruitful method for generating gain-of-function, generally dominant mutants (see, e.g., Hayashi et al, Science (1992) 258: 1350-1353; Weigel et al, Plant Physiology (2000) 122:1003- 1013).
  • the inserted construct provides a molecular tag for rapid identification of the native plant whose mis-expression causes the mutant phenotype.
  • Activation tagging may also cause loss-of -function phenotypes.
  • the insertion may result in disruption of a native plant gene, in which case the phenotype is generally recessive.
  • Activation tagging has been used in various species, including tobacco and Arabidopsis, to identify many different kinds of mutant phenotypes and the genes associated with these phenotypes (Wilson et al, Plant Cell (1996) 8:659-671, Schaffer et al, Cell (1998) 93: 1219-1229; Fridborg et al, Plant Cell (1999)11: 1019-1032;
  • the invention provides a transgenic plant comprising a plant transformation vector comprising a nucleotide sequence that encodes or is complementary to a sequence that encodes a PPRl 1 polypeptide or an ortholog thereof.
  • the transgenic plant is characterized by having increased resistance to pathogens.
  • the present invention further provides a method of producing an altered pathogen resistance phenotype in a plant.
  • the method comprises introducing into plant progenitor cells a vector comprising a nucleotide sequence that encodes or is complementary to a sequence encoding a PPR11 polypeptide or an ortholog thereof and growing a transgenic plant that expresses the nucleotide sequence.
  • the PPRl 1 polypeptide has at least 50% sequence identity to the amino acid sequence presented in SEQ ID NO: 2 and comprises a SANT domain.
  • the PPRl 1 polypeptide has at least 80% or 90% sequence identity to or has the amino acid sequence presented in SEQ U) NO:2.
  • the invention further provides plants and plant parts obtained by the methods described herein.
  • vector refers to a nucleic acid construct designed for transfer between different host cells.
  • an "expression vector” refers to a vector that has the ability to incorporate and express heterologous DNA fragments in a foreign cell. Many prokaryotic and eukaryotic expression vectors are commercially available. Selection of appropriate expression vectors is within the knowledge of those having skill in the art.
  • a "heterologous" nucleic acid construct or sequence has a portion of the sequence that is not native to the plant cell in which it is expressed. Heterologous, with respect to a control sequence refers to a control sequence (i.e. promoter or enhancer) that does not function in nature to regulate the same gene the expression of which it is currently regulating.
  • heterologous nucleic acid sequences are not endogenous to the cell or part of the genome in which they are present, and have been added to the cell, by infection, transfection, microinjection, electroporation, or the like.
  • a "heterologous" nucleic acid construct may contain a control sequence/DNA coding sequence combination that is the same as, or different from a control sequence/DNA coding sequence combination found in the native plant.
  • the term "gene” means the segment of DNA involved in producing a polypeptide chain, which may or may not include regions preceding and following the coding region, e.g. 5' untranslated (5' UTR) or “leader” sequences and 3' UTR or “trailer” sequences, as well as intervening sequences (introns) between individual coding segments (exons) and non-transcribed regulatory sequence.
  • recombinant includes reference to a cell or vector, that has been modified by the introduction of a heterologous nucleic acid sequence or that the cell is derived from a cell so modified.
  • recombinant cells express genes that are not found in identical form within the native (non-recombinant) form of the cell or express native genes that are otherwise abnormally expressed, under expressed or not expressed at all as a result of deliberate human intervention.
  • the term "gene expression” refers to the process by which a polypeptide is produced based on the nucleic acid sequence of a gene. The process includes both transcription and translation; accordingly, “expression” may refer to either a polynucleotide or polypeptide sequence, or both. Sometimes, expression of a polynucleotide sequence will not lead to protein translation. "Over-expression” refers to increased expression of a polynucleotide and/or polypeptide sequence relative to its expression in a wild-type (or other reference [e.g., non-transgenic]) plant and may relate to a naturally-occurring or non-naturally occurring sequence.
  • Ectopic expression refers to expression at a time, place, and/or increased level that does not naturally occur in the non- altered or wild-type plant.
  • Under-expression refers to decreased expression of a polynucleotide and/or polypeptide sequence, generally of an endogenous gene, relative to its expression in a wild-type plant.
  • mi-expression and “altered expression” encompass over-expression, under-expression, and ectopic expression.
  • the term "introduced” in the context of inserting a nucleic acid sequence into a cell means “transfection”, or “transformation” or “transduction” and includes reference to the incorporation of a nucleic acid sequence into a eukaryotic or prokaryotic cell where the nucleic acid sequence may be incorporated into the genome of the cell (for example, chromosome, plasmid, plastid, or mitochondrial DNA), converted into an autonomous replicon, or transiently expressed (for example, transfected rnRNA).
  • a "plant cell” refers to any cell derived from a plant, including cells from undifferentiated tissue (e.g., callus) as well as plant seeds, pollen, progagules and embryos.
  • mutant and wild-type refers to the form in which that trait or phenotype is found in the same variety of plant in nature.
  • modified refers to a change in the phenotype of a transgenic plant relative to the similar non-transgenic plant.
  • an "interesting phenotype (trait)" with reference to a transgenic plant refers to an observable or measurable phenotype demonstrated by a TI and/or subsequent generation plant, which is not displayed by the corresponding non-transgenic (i.e., a genotypically similar plant that has been raised or assayed under similar conditions).
  • An interesting phenotype may represent an improvement in the plant or may provide a means to produce improvements in other plants.
  • An “improvement” is a feature that may enhance the utility of a plant species or variety by providing the plant with a unique and/or novel quality.
  • altered pathogen resistance phenotype refers to detectable change in the response of a genetically modified plant to pathogenic infection, compared to the similar, but non-modified plant.
  • the phenotype may be apparent in the plant itself (e.g. , in growth, viability or particular tissue morphology of the plant) or may be apparent in the ability of the pathogen to proliferate on and/or infect the plant.
  • improved pathogen resistance refers to increased resistance to a pathogen.
  • a "mutant" polynucleotide sequence or gene differs from the corresponding wild type polynucleotide sequence or gene either in terms of sequence or expression, where the difference contributes to a modified plant phenotype or trait.
  • the term “mutant” refers to a plant or plant line which has a modified plant phenotype or trait, where the modified phenotype or trait is associated with the modified expression of a wild type polynucleotide sequence or gene.
  • TI refers to the generation of plants from the seed of TO plants.
  • the TI generation is the first set of transformed plants that can be selected by application of a selection agent, e.g., an antibiotic or herbicide, for which the transgenic plant contains the corresponding resistance gene.
  • a selection agent e.g., an antibiotic or herbicide
  • T2 refers to the generation of plants by self-fertilization of the flowers of TI plants, previously selected as being transgenic.
  • plant part includes any plant organ or tissue, including, without limitation, seeds, embryos, meristematic regions, callus tissue, leaves, roots, shoots, gametophytes, sporophytes, pollen, and microspores.
  • Plant cells can be obtained from any plant organ or tissue and cultures prepared therefrom.
  • the class of plants which can be used in the methods of the present invention is generally as broad as the class of higher plants amenable to transformation techniques, including both monocotyledenous and dicotyledenous plants.
  • transgenic plant includes reference to a plant that comprises within its genome a heterologous polynucleotide.
  • the heterologous polynucleotide can be either stably integrated into the genome, or can be extra-chromosomal.
  • the polynucleotide of the present invention is stably integrated into the genome such that the polynucleotide is passed on to successive generations.
  • a plant cell, tissue, organ, or plant into which the heterologous polynucleotides have been introduced is considered
  • transformed “transfected” or “transgenic”.
  • Direct and indirect progeny of transformed plants or plant cells that also contain the heterologous polynucleotide are also considered transgenic.
  • the enhancer element can cause up-regulation genes in the vicinity, generally within about 10 kilobase (kb) of the insertion.
  • TI plants were exposed to the selective agent in order to specifically recover transformed plants that expressed the selectable marker and therefore harbored T-DNA insertions.
  • Samples of approximately 18 T2 seed were planted, grown to seedlings, and inoculated with P. parasitica spores. Disease symptoms on individual plants were scored based on the number of conidiophores that emerged. Accordingly, plants on which growth of conidiophores was reduced were identified as pathogen resistant.
  • PPRll genes and/or polypeptides may be employed in the development of genetically modified plants having a modified pathogen resistance phenotype.
  • PPRl 1 genes may be used in the generation of crops and/or other plant species that have improved resistance to infection by P. parasitica and other oomycetes and may also be useful the generation of plant with improved resistance to fungal, bacterial, and/or other pathogens. Mis-expression of PPRll genes may thus reduce the need for fungicides and/or pesticides.
  • the modified pathogen resistance phenotype may further enhance the overall health of the plant.
  • Arabidopsis PPRll nucleic acid (coding) sequence is provided in SEQ LD NO:l and in Genbank entry GI 22326553, (At2g26710).
  • the corresponding protein sequence is provided in SEQ ID NO:2.
  • PPRll polypeptide refers to a full-length PPRll protein or a fragment, derivative (variant), or ortholog thereof that is “functionally active,” meaning that the protein fragment, derivative, or ortholog exhibits one or more or the functional activities associated with the polypeptide of SEQ ID NO:2.
  • a functionally active PPRl 1 polypeptide causes an altered pathogen resistance phenotype when mis-expressed in a plant.
  • mis-expression of the functionally active PPRl 1 polypeptide causes increased resistance to P. parasitica and/or other oomycetes.
  • a functionally active PPRll polypeptide is capable of rescuing defective (including deficient) endogenous PPRl 1 activity when expressed in a plant or in plant cells; the rescuing polypeptide may be from the same or from a different species as that with defective activity.
  • a functionally active fragment of a full length PPRll polypeptide i.e., a native polypeptide having the sequence of SEQ ID NO: 2 or a naturally occurring ortholog thereof
  • a PPRll fragment preferably comprises a cytochrome P450 domain, and preferably comprises at least 10, preferably at least 20, more preferably at least 25, and most preferably at least 50 contiguous amino acids of a PPRl 1 protein.
  • Functional domains can be identified using the PFAM program (Bateman A et al., 1999 Nucleic Acids Res 27:260-262; website at pfam.wustl.edu). Using PFAM, a cytochrome P450 domain (PF00067) was identified at residues 47 to 512 of SEQ ID NO: 2.
  • variants of full-length PPRl 1 polypeptides or fragments thereof include polypeptides with amino acid insertions, deletions, or substitutions that retain one of more of the biological properties associated with the full- length PPRll polypeptide.
  • variants are generated that change the post- translational processing of a PPRll polypeptide. For instance, variants may have altered protein transport or protein localization characteristics or altered protein half -life compared to the native polypeptide.
  • PPRl 1 nucleic acid encompasses nucleic acids with the sequence provided in or complementary to the sequence provided in SEQ ID NO:l, as well as functionally active fragments, derivatives, or orthologs thereof.
  • a PPRll nucleic acid of this invention may be DNA, derived from genomic DNA or cDNA, or RNA.
  • a functionally active PPRll nucleic acid encodes or is complementary to a nucleic acid that encodes a functionally active PPRll polypeptide.
  • genomic DNA that serves as a template for a primary RNA transcript (i.e., an mRNA precursor) that requires processing, such as splicing, before encoding the functionally active PPRl 1 polypeptide.
  • a PPRl 1 nucleic acid can include other non-coding sequences, which may or may not be transcribed; such sequences include 5' and 3' UTRs, polyadenylation signals and regulatory sequences that control gene expression, among others, as are known in the art.
  • Some polypeptides require processing events, such as proteolytic cleavage, covalent modification, etc., in order to become fully active.
  • functionally active nucleic acids may encode the mature or the pre-processed PPRl 1 polypeptide, or an intermediate form.
  • a PPRl 1 polynucleotide can also include heterologous coding sequences, for example, sequences that encode a marker included to facilitate the purification of the fused polypeptide, or a transformation marker.
  • a functionally active PPRl 1 nucleic acid is capable of being used in the generation of loss-of-function PPRll phenotypes, for instance, via antisense suppression, co-suppression, etc.
  • a PPRl 1 nucleic acid used in the methods of this invention comprises a nucleic acid sequence that encodes or is complementary to a sequence that encodes a PPRll polypeptide having at least 50%, 60%, 70%, 75%, 80%, 85%, 90%, 95% or more sequence identity to the polypeptide sequence presented in SEQ ID NO:2.
  • a PPRll polypeptide of the invention comprises a polypeptide sequence with at least 50% or 60% identity to the PPRl 1 polypeptide sequence of SEQ ID NO:2, and may have at least 70%, 80%, 85%, 90% or 95% or more sequence identity to the PPRll polypeptide sequence of SEQ ID NO:2.
  • a PPRll polypeptide comprises a polypeptide sequence with at least 50%, 60%, 70%, 80%, 85%, 90% or 95% or more sequence identity to a functionally active fragment of the polypeptide presented in SEQ ID NO:2.
  • a PPRll polypeptide of the invention comprises a polypeptide sequence with at least 50% or 60% identity to the PPRl 1 polypeptide sequence of SEQ ID NO:2, and may have at least 70%, 80%, 85%, 90% or 95% or more sequence identity to the PPRll polypeptide sequence of SEQ ID NO:2.
  • a PPRll polypeptide comprises a polypeptide sequence with at least 50%, 60%, 70%, 80%, 85%, 90% or
  • PPRll polypeptide comprises a polypeptide sequence with at least 50%, 60 %, 70%, 80%, or 90% identity to the polypeptide sequence of SEQ ID NO:2 over its entire length and comprises a cytochrome P450 domain.
  • a PPRll polynucleotide sequence is at least 50% to 60% identical over its entire length to the PPRl 1 nucleic acid sequence presented as SEQ ID NO:l, or nucleic acid sequences that are complementary to such a PPRll sequence, and may comprise at least 70%, 80%, 85%, 90% or 95% or more sequence identity to the PPRl 1 sequence presented as SEQ ID NO: 1 or a functionally active fragment thereof, or complementary sequences.
  • percent (%) sequence identity with respect to a specified subject sequence, or a specified portion thereof, is defined as the percentage of nucleotides or amino acids in the candidate derivative sequence identical with the nucleotides or amino acids in the subject sequence (or specified portion thereof), after aligning the sequences and introducing gaps, if necessary to achieve the maximum percent sequence identity, as generated by the program WU-BLAST-2.0al9 (Altschul et al, J. Mol. Biol. (1990)
  • HSP S and HSP S2 parameters are dynamic values and are established by the program itself depending upon the composition of the particular sequence and composition of the particular database against which the sequence of interest is being searched.
  • a "% identity value” is determined by the number of matching identical nucleotides or amino acids divided by the sequence length for which the percent identity is being reported.
  • Percent (%) amino acid sequence similarity is determined by doing the same calculation as for determining % amino acid sequence identity, but including conservative amino acid substitutions in addition to identical amino acids in the computation.
  • Aromatic amino acids that can be substituted for each other are phenylalanine, tryptophan, and tyrosine; interchangeable hydrophobic amino acids are leucine, isoleucine, methionine, and valine; interchangeable polar amino acids are glutamine and asparagine; interchangeable basic amino acids are arginine, lysine and histidine; interchangeable acidic amino acids are aspartic acid and glutamic acid; and interchangeable small amino acids are alanine, serine, threonine, cysteine and glycine.
  • Derivative nucleic acid molecules of the subject nucleic acid molecules include sequences that hybridize to the nucleic acid sequence of SEQ ID NO:l.
  • the stringency of hybridization can be controlled by temperature, ionic strength, pH, and the presence of denaturing agents such as formamide during hybridization and washing. Conditions routinely used are well known (see, e.g., Current Protocol in Molecular Biology, Vol. 1, Chap. 2.10, John Wiley & Sons, Publishers (1994); Sambrook et al, supra).
  • a nucleic acid molecule of the invention is capable of hybridizing to a nucleic acid molecule containing the nucleotide sequence of SEQ ID NO:l under stringent hybridization conditions that comprise: prehybridization of filters containing nucleic acid for 8 hours to overnight at 65° C in a solution comprising 6X single strength citrate (SSC) (IX SSC is 0.15 M NaCl, 0.015 M Na citrate; pH 7.0), 5X Denhardt's solution, 0.05% sodium pyrophosphate and 100 jug/ml herring sperm DNA; hybridization for 18-20 hours at 65° C in a solution containing 6X SSC, IX Denhardt's solution, 100 ⁇ g/ml yeast tRNA and 0.05% sodium pyrophosphate; and washing of filters at 65° C for 1 h in a solution containing 0.2X SSC and 0.1% SDS (sodium dodecyl sulfate).
  • SSC single strength citrate
  • moderately stringent hybridization conditions comprise: pretreatment of filters containing nucleic acid for 6 h at 40° C in a solution containing 35% formamide, 5X SSC, 50 mM Tris-HCl (pH 7.5), 5 mM EDTA, 0.1% PVP, 0.1% Ficoll, 1% BSA, and 500 ⁇ g/ml denatured salmon sperm DNA; hybridization for 18-20 h at 40° C in a solution containing 35% formamide, 5X SSC, 50 mM Tris-HCl (pH 7.5), 5 mM EDTA, 0.02% PVP, 0.02% Ficoll, 0.2% BSA, 100 ⁇ g/ml salmon sperm DNA, and 10%o (wt/vol) dextran sulfate; followed by washing twice for 1 hour at 55° C in a solution containing 2X SSC and 0.1% SDS.
  • low stringency conditions can be used that comprise: incubation for 8 hours to overnight at 37° C in a solution comprising 20% formamide, 5 x SSC, 50 mM sodium phosphate (pH 7.6), 5X Denhardt's solution, 10% dextran sulfate, and 20 /xg/ml denatured sheared salmon sperm DNA; hybridization in the same buffer for 18 to 20 hours; and washing of filters in 1 x SSC at about 37° C for 1 hour.
  • a number of polynucleotide sequences encoding a PPRll polypeptide can be produced.
  • codons may be selected to increase the rate at which expression of the polypeptide occurs in a particular host species, in accordance with the optimum codon usage dictated by the particular host organism (see, e.g., Nakamura Y et al, Nucleic Acids Res (1999) 27:292).
  • Such sequence variants may be used in the methods of this invention.
  • the methods of the invention may use orthologs of the Arabidopsis PPRll. Methods of identifying the orthologs in other plant species are known in the art.
  • orthologs in different species retain the same function, due to presence of one or more protein motifs and/or 3-dimensional structures.
  • a gene duplication event follows speciation, a single gene in one species, such as Arabidopsis, may correspond to multiple genes (paralogs) in another.
  • paralogs encompasses paralogs.
  • sequence data is available for a particular plant species, orthologs are generally identified by sequence homology analysis, such as BLAST analysis, usually using protein bait sequences.
  • Sequences are assigned as a potential ortholog if the best hit sequence from the forward BLAST result retrieves the original query sequence in the reverse BLAST (Huynen MA and Bork P, Proc Natl Acad Sci (1998) 95:5849-5856; Huynen MA et al, Genome Research (2000) 10:1204-1210).
  • Programs for multiple sequence alignment such as CLUSTAL (Thompson JD et al, 1994, Nucleic Acids Res 22:4673-4680) may be used to highlight conserved regions and/or residues of orthologous proteins and to generate phylogenetic trees.
  • orthologous sequences from two species generally appear closest on the tree with respect to all other sequences from these two species.
  • Structural threading or other analysis of protein folding e.g., using software by ProCeryon, Biosciences, Salzburg, Austria
  • Nucleic acid hybridization methods may also be used to find orthologous genes and are preferred when sequence data are not available.
  • PCR and screening of cDNA or genomic DNA libraries are common methods for finding related gene sequences and are well known in the art (see, e.g., Sambrook, supra; Dieffenbach and Dveksler (Eds.) PCR Primer: A Laboratory Manual, Cold Spring Harbor Laboratory Press, NY, 1989).
  • methods for generating a cDNA library from the plant species of interest and probing the library with partially homologous gene probes are described in Sambrook et al.
  • a highly conserved portion of the Arabidopsis PPRl 1 coding sequence may be used as a probe.
  • PPRl 1 ortholog nucleic acids may hybridize to the nucleic acid of SEQ ID NO:l under high, moderate, or low stringency conditions.
  • a segment of a putative ortholog After amplification or isolation of a segment of a putative ortholog, that segment may be cloned and sequenced by standard techniques and utilized as a probe to isolate a complete cDNA or genomic clone. Alternatively, it is possible to initiate an EST project to generate a database of sequence information for the plant species of interest. In another approach, antibodies that specifically bind known PPRll polypeptides are used for ortholog isolation. Western blot analysis can determine that a PPRl 1 ortholog (i.e., an orthologous protein) is present in a crude extract of a particular plant species. When reactivity is observed, the sequence encoding the candidate ortholog may be isolated by screening expression libraries representing the particular plant species.
  • a PPRl 1 ortholog i.e., an orthologous protein
  • Expression libraries can be constructed in a variety of commercially available vectors, including lambda gtll, as described in Sambrook, et al, supra. Once the candidate ortholog(s) are identified by any of these means, candidate orthologous sequence are used as bait (the "query") for the reverse BLAST against sequences from Arabidopsis or other species in which PPRll nucleic acid and/or polypeptide sequences have been identified.
  • PPRll nucleic acids and polypeptides may be obtained using any available method. For instance, techniques for isolating cDNA or genomic DNA sequences of interest by screening DNA libraries or by using polymerase chain reaction (PCR), as previously described, are well known in the art. Alternatively, nucleic acid sequence may be synthesized. Any known method, such as site directed mutagenesis (Kunkel TA et al, Methods Enzymol. (1991) 204:125-39), may be used to introduce desired changes into a cloned nucleic acid.
  • PCR polymerase chain reaction
  • the methods of the invention involve incorporating the desired form of the PPRl 1 nucleic acid into a plant expression vector for transformation of in plant cells, and the PPRll polypeptide is expressed in the host plant.
  • An isolated PPRll nucleic acid molecule is other than in the form or setting in which it is found in nature and is identified and separated from least one contaminant nucleic acid molecule with which it is ordinarily associated in the natural source of the PPRll nucleic acid.
  • an isolated PPRll nucleic acid molecule includes PPRll nucleic acid molecules contained in cells that ordinarily express PPRll where, for example, the nucleic acid molecule is in a chromosomal location different from that of natural cells.
  • PPRl 1 nucleic acids and polypeptides may be used in the generation of genetically modified plants having a modified pathogen resistance phenotype; in general, improved resistance phenotypes are of interest.
  • Pathogenic infection may affect seeds, fruits, blossoms, foliage, stems, tubers, roots, etc. Accordingly, resistance may be observed in any part of the plant.
  • altered expression of the PPRl 1 gene in a plant is used to generate plants with increased resistance to P. parasitica.
  • plants that mis-express PPRll may also display altered resistance to other pathogens.
  • oomycete pathogens of interest include Pythium spp, Phytophthora spp, Bremia lactucae, Peronosclerospora spp., Pseudoperonospora. Sclerophthora macrospora, Sclerospora graminicola, Plasmopara viticola, and Albugo candidia.
  • Fungal pathogens of interest include Altemaria brassicicola, Botrytis cinerea, Erysiphe cichoracearum, Fusarium oxysporum, Plasmodiophora brassica, Rhizoctonia solani, Colletotrichum coccode, Sclerotinia spp., Aspergillus spp., Penicillium spp., Ustilago spp., and Tilletia spp.
  • Bacterial pathogens of interest include Agrobacterium tumefaciens, Erwinia tracheiphila, Erwinia stewartii, Xanthomonas phaseoli , Erwinia amylovora, Erwinia carotovora, Pseudomonas syringae, Pelargonium spp, Pseudomonas cichorii, Xanthomonas fragariae, Pseudomonas morsprunorum, Xanthomonas campestris.
  • the methods described herein are generally applicable to all plants. Although activation tagging and gene identification is carried out in Arabidopsis, the PPRl 1 gene (or an ortholog, variant or fragment thereof) may be expressed in any type of plant.
  • the invention is directed to crops including maize, soybean, cotton, rice, wheat, barley, tomato, canola, turfgrass, and flax. Other crops include alfalfa, tobacco, and other forage crops.
  • the invention may also be directed to fruit- and vegetable-bearing plants, plants used in the cut flower industry, grain-producing plants, oil-producing plants, and nut-producing plants, among others. The skilled artisan will recognize that a wide variety of transformation techniques exist in the art, and new techniques are continually becoming available.
  • the constructs can be introduced in a variety of forms including, but not limited to as a strand of DNA, in a plasmid, or in an artificial chromosome.
  • the introduction of the constructs into the target plant cells can be accomplished by a variety of techniques, including, but not limited to Agrobacterium-med.ia.ied transformation, electroporation, microinjection, microprojectile bombardment calcium-phosphate-DNA co-precipitation or liposome-mediated transformation of a heterologous nucleic acid.
  • the transformation of the plant is preferably permanent, i.e.
  • a heterologous nucleic acid construct comprising a PPRll polynucleotide may encode the entire protein or a biologically active portion thereof.
  • binary Ti-based vector systems may be used to transfer polynucleotides. Standard Agrobacterium binary vectors are known to those of skill in the art, and many are commercially available (e.g., pBI121 Clontech Laboratories, Palo Alto, CA).
  • Agrobacterium-mediated transformation include transformation of explants of hypocotyl, shoot tip, stem or leaf tissue, derived from sterile seedlings and/or plantlets. Such transformed plants may be reproduced sexually, or by cell or tissue culture. Agrobacterium transformation has been previously described for a large number of different types of plants and methods for such transformation may be found in the scientific literature.
  • Expression (including transcription and translation) of PPRll may be regulated with respect to the level of expression, the tissue type(s) where expression takes place and/or developmental stage of expression.
  • a number of heterologous regulatory sequences e.g., promoters and enhancers are available for controlling the expression of a PPRll nucleic acid. These include constitutive, inducible and regulatable promoters, as well as promoters and enhancers that control expression in a tissue- or temporal-specific manner.
  • Exemplary constitutive promoters include the raspberry E4 promoter (U.S. Patent Nos.
  • tissue-specific promoters include the tomato E4 and E8 promoters (U.S. Patent No. 5,859,330) and the tomato 2AJJ gene promoter (Van Haaren MJJ et al, Plant Mol Bio (1993) 21:625-640).
  • PPRll expression is under the control of a pathogen-inducible promoter (Rushton et al, The Plant Cell (2002) 14:749-762). In one preferred embodiment, PPRll expression is under control of regulatory sequences from genes whose expression is associated with the CsVMV promoter. In yet another aspect, in some cases it may be desirable to inhibit the expression of endogenous PPRl 1 in a host cell.
  • Exemplary methods for practicing this aspect of the invention include, but are not limited to antisense suppression (Smith, et al, Nature (1988) 334:724-726; van der Krol et al., Biotechniques (1988) 6:958-976); co-suppression (Napoli, et al, Plant Cell (1990) 2:279-289); ribozymes (PCT Publication WO 97/10328); and combinations of sense and antisense (Waterhouse, et al, Proc. Natl. Acad. Sci. USA (1998) 95:13959-13964).
  • Methods for the suppression of endogenous sequences in a host cell typically employ the transcription or transcription and translation of at least a portion of the sequence to be suppressed.
  • Such sequences may be homologous to coding as well as non-coding regions of the endogenous sequence.
  • Antisense inhibition may use the entire cDNA sequence (Sheehy et al, Proc. Natl. Acad. Sci. USA (1988) 85:8805-8809), a partial cDNA sequence including fragments of 5' coding sequence, (Cannon et al., Plant Molec. Biol. (1990) 15:39-47), or 3' non-coding sequences (Ch'ng et al., Proc. Natl. Acad. Sci. USA (1989) 86:10006-10010).
  • Cosuppression techniques may use the entire cDNA sequence (Napoli et al, supra; van der Krol et al., The Plant Cell (1990) 2:291-299), or a partial cDNA sequence (Smith et al, Mol. Gen. Genetics (1990) 224:477-481).
  • stage- and tissue-specific gene expression patterns in mutant versus wild-type lines may be determined, for instance, by in situ hybridization. Analysis of the methylation status of the gene, especially flanking regulatory regions, may be performed. Other suitable techniques include overexpression, ectopic expression, expression in other plant species and gene knock-out (reverse genetics, targeted knock-out, viral induced gene silencing [VIGS, see Baulcombe D, (1999) Arch Virol Suppl 15:189-201]).
  • expression profiling is used to simultaneously measure differences or induced changes in the expression of many different genes.
  • Techniques for microarray analysis are well known in the art (Schena M et al, Science (1995) 270:467-470; Baldwin D et al, Cur Opin Plant Biol. (1999) 2(2):96- 103; Dangond F, Physiol Genomics (2000) 2:53-58; van Hal NL et al, J Biotechnol (2000) 78:271-280; Richmond T and Somerville S, Curr Opin Plant Biol (2000) 3:108- 116).
  • Expression profiling of individual tagged lines may be performed. Such analysis can identify other genes that are coordinately regulated as a consequence of the overexpression of the gene of interest, which may help to place an unknown gene in a particular pathway.
  • Analysis of gene products may include recombinant protein expression, antisera production, immunolocalization, biochemical assays for catalytic or other activity, analysis of phosphorylation status, and analysis of interaction with other proteins via yeast two-hybrid assays.
  • Pathway analysis may include placing a gene or gene product within a particular biochemical, metabolic or signaling pathway based on its mis-expression phenotype or by sequence homology with related genes.
  • analysis may comprise genetic crosses with wild-type lines and other mutant lines (creating double mutants) to order the gene in a pathway, or determining the effect of a mutation on expression of downstream "reporter" genes in a pathway.
  • the invention further provides a method of identifying plants that have mutations in endogenous PPRll that confer increased pathogen resistance, and generating pathogen- resistant progeny of these plants that are not genetically modified.
  • TILLING for targeting induced local lesions in genomes
  • mutations are induced in the seed of a plant of interest, for example, using EMS treatment.
  • the resulting plants are grown and self -fertilized, and the progeny are used to prepare DNA samples.
  • PPRl 1- specific PCR are used to identify whether a mutated plant has a PPRl 1 mutation.
  • Plants having PPRll mutations may then be tested for pathogen resistance, or alternatively, plants may be tested for pathogen resistance, and then PPRl 1-specific PCR is used to determine whether a plant having increased pathogen resistance has a mutated PPRll gene.
  • TILLING can identify mutations that may alter the expression of specific genes or the activity of proteins encoded by these genes (see Colbert et al (2001) Plant Physiol 126:480-484; McCallum et al (2000) Nature Biotechnology 18:455-457).
  • a candidate gene/Quantitative Trait Locus (QTLs) approach can be used in a marker-assisted breeding program to identify alleles of or mutations in the PPRll gene or orthologs of PPRll that may confer increased resistance to pathogens (see Foolad et al., Theor Appl Genet. (2002) 104(6-7):945-958; Rothan et al, Theor Appl Genet (2002) 105(1): 145-159); Deldcers and Hospital, Nat Rev Genet. (2002) Jan;3(l):22- 32).
  • a PPRll nucleic acid is used to identify whether a plant having increased pathogen resistance has a mutation in endogenous PPRl 1 or has a particular allele that causes the increased pathogen resistance.
  • T2 seed was collected from TI plants and stored in an indexed collection, and a portion of the T2 seed was accessed for the screen.
  • Approximately 18 T2 seeds from 757 TI plants having a dwarf phenotype were planted in soil. The seed were stratified for three days and then grown in the greenhouse for seven days. The seedlings were inoculated with approximately lxlO 5 conidia per ml P. parasitica spores and incubated in a dew room at 18°C and 100% humidity for 24 hours. The plants were then moved to a growth room at 20°C and 60% relative humidity with ten-hour long light period for six days. Individual plants were evaluated for the presence or absence of conidiophores on cotyledons.
  • Lines in which at least a single plant showed no conidiophore growth were re-tested in a secondary screen by releasing three sets of 18 seed and screening for resistance to P. parasitica growth as before. Lines in which a significant number of plants showed no conidiophores after infection were subjected to a tertiary screen. Approximately 54 T2 seed were released, planted individually and infected with P. parasitica as before.
  • the plants were evaluated for the number of conidiophores growing on a single cotyledon and ranked by the following scoring system: a score of 0 indicates 0 conidiophores per cotyledon, 1 indicates 1-5 conidiophores per cotyledon, 2 indicates 6-10 conidiophores per cotyledon, 3 indicates 11-20 conidiophores per cotyledon, and 4 indicates greater than 20 conidiophores per cotyledon.
  • the ACTTAG line designated W0000196036 was identified as having an increased resistance phenotype. Specifically, of the 39 T2 plants from W00019036, 23 scored as 0 (59%), 3 as 1 (7.7%), 3 as 2 (7.7%), 10 as 3(25.6%) and 0 as 4 (0%). Of the 270 control wild-type Col-0 plants evaluated, 47 plants scored 0 (17.9%), 4 as 1 (1.5%), 24 as 2 (9.2%), 157 as 3 (49%) and 30 as 4 (11.5%).
  • flanking sequences were subjected to a basic BLASTN search and/or a search of the Arabidopsis Information Resource (TATJR.) database (available at the arabidopsis.org website), which revealed sequence identity to nucleotides 50415-50739 of BAG T9J22 and F18A8, (GI 6598390); which is also annotated as nucleotides 305-629 on chromosome 2, section 149.
  • Sequence analysis revealed that the T-DNA had inserted in the vicinity (i.e., within about 10 kb) of the gene whose nucleotide sequence is presented as SEQ ID NO: 1 (At2g26710), and which we designated PPR 11.
  • the right border was approximately 83 bp 5 ' of the start codon of SEQ ID NO:l.
  • amino acid sequence predicted from the PPRl 1 nucleic acid sequence is presented in SEQ JD NO:2 (alias F18A8.8; At2g26710).
  • DNA was isolated from line W000196036 and subjected to DNA gel blot analysis using a portion of pSKI015 as a probe. Analysis indicated that there was a single T-DNA insert in W000196036. To detect lines containing or lacking the insert, PCR analysis was performed using DNA oligonucleotide primers that hybridize to sequences in pSKI015 or flanking the insert.
  • RT-PCR analysis showed that the PPRll gene was overexpressed in plants from the line displaying the P. parasitica resistance phenotype.
  • RNA was extracted from tissues derived from plants exhibiting the resistance phenotype and from wild type COL-0 plants.
  • RT-PCR was performed using primers specific to the sequence presented as SEQ JD NO:l, to another predicted genes in the vicinity of the T-DNA insertion (At2g26720), and to a constitutively expressed actin (positive control). The results showed that plants displaying the PPRll phenotype over-expressed the mRNA for the PPRll gene, indicating the enhanced expression of the PPRll gene is correlated with the PPRll phenotype.

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention porte sur des plantes ayant un phénotype de résistance pathogène causé par l'expression altérée d'un acide nucléique PPR11. L'invention porte également sur des procédés de génération de plantes à phénotype de résistance pathogène.
PCT/US2004/010174 2003-04-01 2004-03-31 Generation de plantes a resistance pathogene amelioree Ceased WO2004086853A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45929703P 2003-04-01 2003-04-01
US60/459,297 2003-04-01

Publications (2)

Publication Number Publication Date
WO2004086853A2 true WO2004086853A2 (fr) 2004-10-14
WO2004086853A3 WO2004086853A3 (fr) 2006-01-26

Family

ID=33131877

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/010174 Ceased WO2004086853A2 (fr) 2003-04-01 2004-03-31 Generation de plantes a resistance pathogene amelioree

Country Status (1)

Country Link
WO (1) WO2004086853A2 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1313867A2 (fr) * 2000-08-24 2003-05-28 The Scripps Research Institute Sequences nucleotidiques de plantes a stress regule, plantes transgeniques contenant ces sequences, et methodes d'utilisation stress-regulated nucleotide sequences of plants, transgenic plants containing same, and methods of use

Also Published As

Publication number Publication date
WO2004086853A3 (fr) 2006-01-26

Similar Documents

Publication Publication Date Title
US20090089892A1 (en) Generation of plants with improved pathogen resistance
US8222485B2 (en) Generation of plants with improved pathogen resistance
US8044262B2 (en) Generation of plants with improved drought tolerance
US7754945B2 (en) Generation of plants with improved drought tolerance
US7829759B2 (en) Generation of plants with improved pathogen resistance
WO2008054890A1 (fr) Génération de plantes avec une meilleure résistance aux agents pathogènes
US20070266454A1 (en) Generation of Plants with Improved Drought Tolerance
WO2004086853A2 (fr) Generation de plantes a resistance pathogene amelioree

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase